Clinical Trial

A Study for Cerebral Open Flow Microperfusion

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the safety and feasibility of intra-operative microperfusion during a planned neurosurgical resection of diseased brain parenchyma, including either an epileptic focus requiring temporal lobectomy or a glioma. Devices used for microperfusion are Joanneum Research cerebral open flow microperfusion (OFM) catheters, push and pull tubing, and MPP102-II pump.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-25.
Trial Details
NCT Number NCT07089758
Lead Sponsor Mayo Clinic
Collaborators: National Cancer Institute (NCI)
Conditions Glioma, Glioblastoma
Enrollment 6 participants
Start Date 2026-10
Primary Completion 2028-02 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-23